FREDERICK, Md. (PRWEB) October 06, 2020
The U-Strip™ is a patented transdermal insulin delivery patch system that uses special ultrasound frequencies to expand the pores of the skin and deliver insulin into the bloodstream – No Needles. Insulin is too large to be absorbed by the skin normally. The use of ultrasound dilates the skin pores and pushes the drug into the tissue. Now entering Phase-3 clinical trials in both the United States and South Korea, the U-Strip™ Insulin system is nearing regulatory acceptance.
The new Transdermal Laboratory is working upon an Insulin Patch as the lead product, to be followed by a Parkinson’s Patch, one for Multiple Sclerosis and a Migraine Patch. The new Transdermal Laboratory in Frederick, MD is just being staffed to explore these and other drug delivery projects, through assistance provided by the State of Maryland. Over the next 18 months the Company expects to add 15 new Maryland technical jobs.
TSG located in Frederick, MD is committed to developing innovative drug delivery systems that enhance health and improve the quality of life. The company has developed an Ultrasonic active patch delivery system U-STRIPTM that uses special ultrasound frequencies to expand the pores of the skin and deliver drugs into the bloodstream...TSG’s first product is a painless Needle-Free transdermal insulin delivery patch system. Since 2016, TSG has been a pioneer in the development of ultrasonic technologies for the pharmaceutical and cosmetic industry.
For more information on Transdermal Specialties Global please call 484.716.2165.